Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition

Context: This article reviews the use of albumin microcapsules 3–4 mm in size containing cytokine inhibiting drugs which include neutralizing antibodies to TNF and IL1, CNI-1493, antisense oligonucleotides to TNF and NF-kappaB, and the antioxidant catalase. Objective: Describe the effects, cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Oettinger, Carl W., D'Souza, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433085/
https://www.ncbi.nlm.nih.gov/pubmed/22348221
http://dx.doi.org/10.3109/02652048.2012.658443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433085/
https://www.ncbi.nlm.nih.gov/pubmed/22348221
http://dx.doi.org/10.3109/02652048.2012.658443

Ejemplares similares